John E. Leonard's most recent trade in Vaccinex Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaccinex Inc | John E. Leonard | SVP, Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Vaccinex Inc | John E. Leonard | SVP, Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vaccinex Inc | John E. Leonard | SVP, Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2021 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.10 per share. | 24 Jul 2020 | 1,258 | 1,258 (0%) | 0% | 7.1 | 8,932 | Common Stock |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2020 | 1,258 | 23,150 | - | - | Stock Option (Right to Buy) | |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 24 Jul 2020 | 1,000 | 2,258 (0%) | 0% | 3.9 | 3,900 | Common Stock |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2020 | 1,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 14 Jul 2020 | 1,000 | 2,258 (0%) | 0% | 3.9 | 3,900 | Common Stock |
| Vaccinex Inc | John E. Leonard | SVP, Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2020 | 1,000 | 3,000 | - | - | Stock Option (Right to Buy) |